| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |